This panel screens for three high-consequence viral pathogens across parallel rapid lateral flow tracks: * 1. Hepatitis B Surface Antigen (HBsAg) - Rapid: A direct antigen detection test that screens for the outer envelope protein of the Hepatitis B Virus. Its presence indicates active acute or chronic Hepatitis B viral replication and infectivity. * 2. HIV 1 & 2 Antibodies - Rapid: A serological test that detects circulating antibodies manufactured by the immune system against Human Immunodeficiency Virus Type 1 and Type 2, providing an essential diagnostic check for retroviral exposure. * 3. Hepatitis C Virus (HCV) Antibody - Rapid: A qualitative screen that identifies circulating antibodies directed against structural and non-structural proteins of the Hepatitis C Virus, indicating past exposure or chronic active HCV infection. * Pathologist Clinical Virology Remarks: Medical review and validation mapping rapid test line bands against clinical history to guide confirmatory ELISA or molecular PCR testing.

SEROLOGY

The serum sample is processed using automated and visually verified Rapid Lateral Flow Immunochromatographic Assays. * Sample Application: Centrifuged patient serum is loaded into the designated sample well of the specialized test cassette along with an optimized chemical assay buffer. * Capillary Migration: The fluid moves by capillary action along a porous nitrocellulose membrane, rehydrating colloidal gold or colored latex particles conjugated to specific capture antibodies or recombinant viral antigens. * Capture at the Test Line (T-Line): * For HBsAg: The test line contains immobilized monoclonal anti-HBs antibodies that capture the HBsAg-antigen-gold complex in a sandwich format. * For HIV & HCV: The test line is coated with synthetic recombinant viral antigens that capture specific anti-HIV or anti-HCV antibodies present in the patient's serum. * A distinct colored band forms at the "T" line if target antigens or antibodies are present. * Internal Control Line (C-Line): Excess conjugate continues along the membrane to the control line ("C"), where it binds to immobilized anti-species antibodies. A visible line at the "C" mark validates that adequate liquid volume was added and capillary flow functioned properly, ruling out false-negative invalid runs.

SERUM 3ML

* No Fasting Required: Strict fasting is entirely unnecessary. Routine meals, beverages, and daily medications do not alter circulating viral surface antigens or specific viral antibodies. * Understanding the "Window Period": Rapid serological tests depend on the presence of viral surface antigens or host antibodies. If a potential exposure occurred very recently (within 1 to 4 weeks), circulating antibody levels may fall below the detection limit (window period). Documenting the exact date of potential exposure ensures appropriate testing schedules. * Pre-Operative Documentation: If this panel is required for surgical clearance or endoscopic procedures, ensure the test is scheduled at least 24 to 48 hours prior to admission to allow time for confirmatory testing if a reactive band is observed. * Sample Required: Requires 3 ml of venous whole blood collected cleanly into a red-top or gold-top gel-barrier tube to yield clear Serum. Hemolyzed or severely lipemic samples should be avoided to prevent background membrane discoloration.

QUESTION 1: Why does the Virology Profile Triple HHH Rapid test report require a 6-hour turnaround window? ANSWER: While the lateral flow membrane reaction develops within 15 to 20 minutes on the test strip, providing a validated pathology report involves proper laboratory phases. This includes allowing the venous blood to form a clean clot, high-speed centrifugation to separate clear serum from red cells, setting up calibrated rapid cassettes for HBsAg, HIV, and HCV simultaneously, inspecting control and test bands under standardized lighting, and final verification by our pathodiagnostic team. QUESTION 2: What does "Triple H" stand for in medical testing? ANSWER: "Triple H" stands for the three major chronic blood-borne viral infections: HBsAg (Hepatitis B Surface Antigen), HIV 1 & 2 (Human Immunodeficiency Virus), and HCV (Hepatitis C Virus). They are screened together because they share similar modes of transmission and carry significant public health implications. QUESTION 3: What is the difference between a Rapid Screening Test and a Confirmatory ELISA test? ANSWER: A rapid screening test is a qualitative point-of-care tool designed to provide fast results (yes/no) with high sensitivity. However, because rapid tests can occasionally produce false-reactive results due to cross-reacting proteins, international guidelines require that any reactive rapid result be confirmed with an advanced laboratory test, such as an ELISA, CLIA, or molecular PCR assay. QUESTION 4: What is the "Window Period" for these three viral infections? ANSWER: The window period is the time between initial exposure to a virus and the moment a test can reliably detect it. For Hepatitis B (HBsAg), the window period is roughly 3 to 6 weeks; for HIV antibody tests, it is 3 to 12 weeks; and for Hepatitis C antibody tests, it is 4 to 10 weeks. Testing too soon after an exposure may produce a false-negative result. QUESTION 5: Do I need to fast before giving a blood sample for this rapid viral panel? ANSWER: No. Fasting is entirely unnecessary. Eating meals or drinking water does not alter viral surface antigens or circulating antibodies, allowing you to provide your blood sample at any convenient time. QUESTION 6: Why is the HBsAg test looking for an "antigen" while HIV and HCV tests look for "antibodies"? ANSWER: Hepatitis B virus sheds vast quantities of its outer protein coat (Hepatitis B Surface Antigen - HBsAg) directly into the blood during active infection, making direct antigen detection the fastest way to spot it. For HIV and Hepatitis C, detecting the specific defense antibodies produced by your immune system is the standard serological screening method. QUESTION 7: Can a past Hepatitis B vaccination cause a positive result on this rapid HBsAg test? ANSWER: No. The Hepatitis B vaccine contains purified proteins that stimulate your body to produce Hepatitis B Surface Antibodies (Anti-HBs), which provide immunity. The HBsAg test checks for the Surface Antigen (the virus itself), not protective antibodies, so vaccinated individuals will test negative on an HBsAg screen. QUESTION 8: What should I do if one of the tests in the Triple H panel returns "Reactive"? ANSWER: A reactive result is a preliminary screening finding that requires confirmation. The immediate step is to consult a physician or infectious disease specialist, who will order confirmatory testing—such as an ELISA, CLIA, or molecular PCR viral load test—to determine whether an active infection is present. QUESTION 9: Can common colds, viral fevers, or medications cause a false-positive rapid test? ANSWER: While modern rapid cassettes have high specificity, severe auto-immune conditions, acute viral infections, pregnancy, or heterophile antibodies in the blood can occasionally cause non-specific cross-reactivity, resulting in a faint false-positive line. This is why confirmatory laboratory testing is standard medical protocol. QUESTION 10: Why is this panel mandatory before surgical operations and dental procedures? ANSWER: Surgery involves exposure to blood and sharp instruments. Screening before an operation protects the surgical and nursing staff, ensures appropriate infection control protocols are maintained, and helps the clinical team plan post-operative monitoring for the patient. QUESTION 11: Can Hepatitis C be completely cured if detected early? ANSWER: Yes. Modern medical treatments feature direct-acting antiviral (DAA) medications that can cure over 95% of Hepatitis C infections within 8 to 12 weeks of oral therapy, making early detection through screening highly beneficial. QUESTION 12: Is a rapid test accurate enough to clear someone after an occupational needle-stick injury? ANSWER: A rapid test performed immediately after an injury provides a crucial baseline to prove that the healthcare worker was negative at the time of the event. However, follow-up testing at 4 to 6 weeks and 3 months (or early molecular PCR testing) is required to ensure no transmission occurred during the window period. QUESTION 13: What does an "Invalid" test result mean on a laboratory report? ANSWER: An invalid result means the internal Control ("C") line failed to appear on the test cassette. This indicates a technical fault, such as insufficient sample volume or a damaged strip. The laboratory will automatically re-run the test using a fresh cassette at no additional cost. QUESTION 14: How are HIV, Hepatitis B, and Hepatitis C transmitted between individuals? ANSWER: All three viruses are blood-borne pathogens. The primary routes of transmission include unprotected sexual intercourse, sharing contaminated needles or syringes, receiving unscreened blood or organ donations, unsterilized tattooing or body piercing tools, and transmission from mother to baby during pregnancy or delivery. QUESTION 15: Can an individual contract these viruses through casual contact like hugging, shaking hands, or sharing food? ANSWER: No. HIV, Hepatitis B, and Hepatitis C cannot be transmitted through casual contact, sharing food or drinking water, sneezing, coughing, hugging, or using the same toilet seats. QUESTION 16: Is this blood collection safe for pregnant women? ANSWER: Yes, completely safe and standard. It requires a routine venous blood draw (3 ml) that takes only a minute and carries zero physical risk to the mother or developing fetus. Identifying maternal infection early allows doctors to take steps (such as administering immunoglobulins and antivirals) to prevent transmission to the newborn. QUESTION 17: What is the difference between a Hepatitis C Antibody test and an HCV RNA PCR test? ANSWER: The rapid HCV antibody test checks if your immune system has ever encountered the virus; it can stay positive for life even after the infection is cured. The HCV RNA PCR test checks for the actual virus in your blood, confirming whether you have an active, ongoing infection that requires treatment. QUESTION 18: Why is clear Serum preferred over whole blood for this rapid panel? ANSWER: Centrifuging blood to separate clear serum removes red blood cells, which can sometimes cause background staining or obscure faint test lines on nitrocellulose membranes, ensuring clean, unambiguous visual reading. QUESTION 19: How can our family securely access and download our final digital PDF report file? ANSWER: As soon as your rapid immunochromatographic screening analysis is verified and signed off by our laboratory pathology team, your secure digital report can be downloaded instantly from www.drpatholab.in using your registered credentials. QUESTION 20: Are my personal health records, viral screening results, and laboratory data kept private? ANSWER: Absolute adherence to strict medical privacy standards, encrypted digital data channels, and sample identity protocols guarantees that your entire diagnostic profile remains strictly confidential and secure.